Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Blueprint Medicines Corp (BPMC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/25/2023 8-K Other Events  Interactive Data
08/24/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
06/30/2023 8-K Other Events  Interactive Data
05/25/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "FIRST AMENDMENT TO FINANCING AGREEMENT"
05/10/2023 ARS/A Form ARS/A - Annual Report to Security Holders: [Amend]
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/28/2023 8-K Quarterly results
02/27/2023 8-K Investor presentation
Docs: "INTRODUCTION CHIEF EXECUTIVE OFFICER BLUEPRINT MEDICINES KATE"
02/23/2023 8-K Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  ...
Docs: "Blueprint Medicines to Regain Global Rights to GAVRETO from Roche"
02/14/2023 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 7.2% stake in BLUEPRINT MEDICINES CORP
02/10/2023 8-K Quarterly results
02/09/2023 SC 13G/A FMR LLC reports a 15% stake in BLUEPRINT MEDICINES CORP
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/26/2023 SC 13G/A BlackRock Inc. reports a 10.5% stake in BLUEPRINT MEDICINES CORP
01/20/2023 SC 13G/A BlackRock Inc. reports a 10.5% stake in BLUEPRINT MEDICINES CORP
01/09/2023 8-K Investor presentation
Docs: "KATE HAVILAND, PRESIDENT AND CEO J.P. MORGAN HEALTHCARE CONFERENCE"
01/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Blueprint Medicines Appoints John Tsai, M.D. to its Board of Directors"
12/27/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "CONSULTING AGREEMENT",
"AMENDMENT AGREEMENT"
12/06/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "AMENDED AND RESTATED BYLAWS OF BLUEPRINT MEDICINES CORPORATION ARTICLE I Stockholders SECTION 1. Annual Meeting . The annual meeting of stockholders shall be held at the hour, date and place within or without the United States which is fixed by the Corporation’ s Board of Directors , which time, date and place may subsequently be changed at any time, before or after the notice for such meeting has been sent to the stockholders, by vote of the Board of Directors. The Board of Directors may, in its sole discretion, determine that a meeting of stockholders shall not be held at any place, but may instead be held solely by means of remote communication as authorized by Section 211 of the General Corporation Law of the State of Delaware . In the absence of any such designation or determination, ..."
11/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/01/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/01/2022 8-K Quarterly results
09/23/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT This First Amendment to Amended and Restated Employment Agreement is dated as of September 23, 2022 , between Blueprint Medicines Corporation, a Delaware corporation , and Kathryn Haviland . Capitalized terms used and not defined herein shall have the meanings ascribed to such terms in the Employment Agreement . WHEREAS, the Company and the Executive are parties to the Amended and Restated Employment Agreement dated as of January 4, 2022 and effective as of April 4, 2022 ; and WHEREAS, the Company and the Executive desire to amend the Employment Agreement as set forth below; NOW, THEREFORE, for good and valuable consideration, the receipt of which is hereby confirmed, the Company and the Executive agree that the Employment Agreem...",
"THIRD AMENDMENT TO EMPLOYMENT AGREEMENT This Third Amendment to Employment Agreement is dated as of September 23, 2022 , between Blueprint Medicines Corporation, a Delaware corporation , and Michael Landsittel . Capitalized terms used and not defined herein shall have the meanings ascribed to such terms in the Employment Agreement . WHEREAS, the Company and the Executive are parties to the Employment Agreement dated as of November 22, 2017, as amended by the First Amendment to Employment Agreement dated as of January 30, 2019, and as further amended by the Second Amendment to Employment Agreement dated as of December 22, 2021 ; and WHEREAS, the Company and the Executive desire to amend the Employment Agreement as set forth below; NOW, THEREFORE, for good and valuable consideration, the rec...",
"FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT This First Amendment to Amended and Restated Employment Agreement is dated as of September 23, 2022 , between Blueprint Medicines Corporation, a Delaware corporation , and Christina Rossi . Capitalized terms used and not defined herein shall have the meanings ascribed to such terms in the Employment Agreement . WHEREAS, the Company and the Executive are parties to the Amended and Restated Employment Agreement dated January 4, 2022 and effective as of April 4, 2022 ; and WHEREAS, the Company and the Executive desire to amend the Employment Agreement as set forth below; NOW, THEREFORE, for good and valuable consideration, the receipt of which is hereby confirmed, the Company and the Executive agree that the Employment Agreement is ...",
"SECOND AMENDMENT TO EMPLOYMENT AGREEMENT This Second Amendment to Employment Agreement is dated as of September 23, 2022 , between Blueprint Medicines Corporation, a Delaware corporation , and Fouad Namouni, M.D. . Capitalized terms used and not defined herein shall have the meanings ascribed to such terms in the Employment Agreement . WHEREAS, the Company and the Executive are parties to the Employment Agreement effective as of September 1, 2020, as amended by the First Amendment to Employment Agreement dated as of December 22, 2021 ; and WHEREAS, the Company and the Executive desire to amend the Employment Agreement as set forth below; NOW, THEREFORE, for good and valuable consideration, the receipt of which is hereby confirmed, the Company and the Executive agree that the Employment Agr...",
"SECOND AMENDMENT TO EMPLOYMENT AGREEMENT This Second Amendment to Employment Agreement is dated as of September 23, 2022 , between Blueprint Medicines Corporation, a Delaware corporation , and Tracey McCain . Capitalized terms used and not defined herein shall have the meanings ascribed to such terms in the Employment Agreement . WHEREAS, the Company and the Executive are parties to the Employment Agreement dated as of September 6, 2016, as amended by the First Amendment to Employment Agreement dated as of December 22, 2021 ; and WHEREAS, the Company and the Executive desire to amend the Employment Agreement as set forth below; NOW, THEREFORE, for good and valuable consideration, the receipt of which is hereby confirmed, the Company and the Executive agree that the Employment Agreement is ...",
"SECOND AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT",
"SECOND AMENDMENT TO EMPLOYMENT AGREEMENT",
"SECOND AMENDMENT TO EMPLOYMENT AGREEMENT This Second Amendment to Employment Agreement is dated as of September 23, 2022 , between Blueprint Medicines Corporation, a Delaware corporation , and Percy Carter Ph. D., MBA . Capitalized terms used and not defined herein shall have the meanings ascribed to such terms in the Employment Agreement . WHEREAS, the Company and the Executive are parties to the Employment Agreement effective as of May 19, 2021, as amended by the First Amendment to Employment Agreement dated as of December 22, 2021 ; and WHEREAS, the Company and the Executive desire to amend the Employment Agreement as set forth below; NOW, THEREFORE, for good and valuable consideration, the receipt of which is hereby confirmed, the Company and the Executive agree that the Employment Agr...",
"THIRD AMENDMENT TO EMPLOYMENT AGREEMENT This Third Amendment to Employment Agreement is dated as of September 23, 2022 , between Blueprint Medicines Corporation, a Delaware corporation , and Debra Durso-Bumpus . Capitalized terms used and not defined herein shall have the meanings ascribed to such terms in the Employment Agreement . WHEREAS, the Company and the Executive are parties to the Employment Agreement dated as of November 22, 2017, as amended by the First Amendment to Employment Agreement dated as of February 10, 2020, and the Second Amendment to Employment Agreement dated as of December 22, 2021 ; and WHEREAS, the Company and the Executive desire to amend the Employment Agreement as set forth below; NOW, THEREFORE, for good and valuable consideration, the receipt of which is here...",
"SECOND AMENDMENT TO EMPLOYMENT AGREEMENT"
09/07/2022 8-K Investor presentation
Docs: "BLUEPRINT MEDICINES COMPANY OVERVIEW SEPTEMBER 2022"
08/17/2022 8-K Quarterly results
08/02/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/02/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/02/2022 8-K Quarterly results
Docs: "Blueprint Medicines Reports Second Quarter 2022 Results"
06/30/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy